GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED

Golden Throat Holdings Group Company Limited

6896

KYG3961J1022

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 01:24:14 2024-05-29 am EDT			5-day change	1st Jan Change
3.73 ^HKD	-1.84%		-1.58%	+11.34%

May. 01	Golden Throat’s Profit Declines 11% in 2023	MT
Mar. 27	Golden Throat Holdings Group Company Limited Updates to Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 26 June 2024	CI

Golden Throat Holdings Group Company Limited Updates to Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 26 June 2024

March 27, 2024 at 10:04 am EDT

Golden Throat Holdings Group Company Limited updated to proposed final dividend of HKD 0.6 per share for the year ended 31 December 2023, Payment date is 26 June 2024. Date of shareholders' approval 05 June 2024. Ex-dividend date 14 June 2024, Record date 18 June 2024.

Latest news about Golden Throat Holdings Group Company Limited

Golden Throat’s Profit Declines 11% in 2023	May. 01	MT
Golden Throat Holdings Group Company Limited Updates to Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 26 June 2024	Mar. 27	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Golden Throat’s Profit to See 110% Boost in H1	23-08-15	MT
Golden Throat Holdings Group Company Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023	23-08-14	CI
Golden Throat Holdings Group Company Limited Declares Final Dividend for the Year Ended 31 December 2022	23-06-14	CI
Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2022	23-05-17	CI
Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023	23-03-29	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Golden Throat Forecasts 50% Rise in 2022 Profit; Shares Climb 7%	23-03-10	MT
Golden Throat Holdings Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2022	23-03-09	CI
Golden Throat Holdings Group's H1 Net Profit Falls 30.4%	22-08-25	MT
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Golden Throat Warns of 30% Profit Drop in H1	22-08-05	MT
Golden Throat Holdings Group Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022	22-08-05	CI
Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 13 June 2022	22-03-30	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Golden Throat Holdings Group Company Limited Announces Resignation of Lu Xinghong as Executive Director	22-03-25	CI
Golden Throat Holdings Group Company Limited Provides Earnings Guidance for the Fiscal Year Ended December 31, 2021	22-03-16	CI
Golden Throat Holdings Group Company Limited Announces Management Changes	22-03-09	CI
Hong Kong Stocks Rebound from 14-Month Low; Golden Throat Tanks 38%	21-12-01	MT
Golden Throat Shareholders Reject $68 Million Go-Private Offer; Shares Tank 34%	21-12-01	MT
Golden Throat Shareholders to Vote Nov. 30 on $68 Million Go-Private Deal	21-10-28	MT
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI

Chart Golden Throat Holdings Group Company Limited

Duration

Period

Chart Golden Throat Holdings Group Company Limited

More charts

Company Profile

Golden Throat Holdings Group Company Limited is principally engaged in the manufacture and sales of pharmaceutical, healthcare food and other products. The Companyâs flagship product is Golden Throat Lozenges (OTC), which is a type of lozenge mainly designed to relieve symptoms of sore, dry throat and hoarse voice caused by acute pharyngitis. The Company's subsidiaries include Golden Throat Industrial Holdings Limited, Guangxi Golden Throat Investment Consulting Co., Ltd. and Guangxi Golden Throat Co., Ltd..

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED	+11.34%	360M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.99%	42.25B
OTSUKA HOLDINGS CO., LTD.	+15.28%	21.27B
SANDOZ GROUP AG	+19.33%	15.23B
CIPLA LIMITED	+19.04%	14.36B
ZYDUS LIFESCIENCES LIMITED	+50.38%	12.74B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.12%	6.61B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.28%	5.66B